Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri  Hideaki Matsui, Naoya.

Slides:



Advertisements
Similar presentations
Development of a Rab9 Transgenic Mouse and Its Ability to Increase the Lifespan of a Murine Model of Niemann-Pick Type C Disease  Tatiana Kaptzan, Sally.
Advertisements

Volume 26, Issue 2, Pages (January 2016)
Volume 35, Issue 1, Pages (July 2002)
Volume 18, Issue 8, Pages (February 2017)
Volume 34, Issue 6, Pages (September 2015)
Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells  Fereshteh Karimzadeh,
Volume 13, Issue 2, Pages (October 2015)
Athena Kalyvas, Samuel David  Neuron 
Requirement of Zinc Transporter SLC39A7/ZIP7 for Dermal Development to Fine-Tune Endoplasmic Reticulum Function by Regulating Protein Disulfide Isomerase 
Volume 7, Issue 3, Pages (May 2014)
Volume 23, Issue 8, Pages (May 2018)
Volume 15, Issue 8, Pages (May 2016)
Volume 20, Issue 1, Pages (July 2017)
Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling
Hermann Broder Schmidt, Rajat Rohatgi  Cell Reports 
Volume 16, Issue 3, Pages (February 2006)
Molecular Therapy - Nucleic Acids
Volume 24, Issue 13, Pages e5 (September 2018)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 29, Issue 2, Pages (February 2008)
Melissa Hernandez-Fleming, Ethan W. Rohrbach, Greg J. Bashaw 
Age-Dependent Decrease in Chaperone Activity Impairs MANF Expression, Leading to Purkinje Cell Degeneration in Inducible SCA17 Mice  Su Yang, Shanshan.
Bacterial Carriers for Glioblastoma Therapy
Volume 123, Issue 6, Pages (December 2005)
Volume 10, Issue 8, Pages (March 2015)
Volume 87, Issue 2, Pages (July 2015)
Volume 21, Issue 12, Pages (December 2017)
Zijing Chen, Hsiang-Chin Chen, Craig Montell  Cell Reports 
Molecular Therapy - Methods & Clinical Development
Volume 27, Issue 19, Pages e5 (October 2017)
Volume 19, Issue 10, Pages (October 2011)
Volume 10, Issue 4, Pages (April 2018)
Volume 10, Issue 8, Pages (March 2015)
Volume 21, Issue 1, Pages (January 2013)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 12, Issue 8, Pages (August 2015)
Volume 4, Issue 1, Pages (July 2013)
Volume 23, Issue 8, Pages (May 2018)
Ramiro E. Verdun, Laure Crabbe, Candy Haggblom, Jan Karlseder 
Volume 27, Issue 22, Pages e4 (November 2017)
Volume 21, Issue 15, Pages (August 2011)
Volume 4, Issue 1, Pages (July 2013)
Volume 42, Issue 2, Pages e3 (July 2017)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Volume 11, Issue 4, Pages (April 2015)
René Keil, Katrin Rietscher, Mechthild Hatzfeld 
VRILLE Controls PDF Neuropeptide Accumulation and Arborization Rhythms in Small Ventrolateral Neurons to Drive Rhythmic Behavior in Drosophila  Kushan.
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 18, Issue 8, Pages (February 2017)
ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor
Yunpeng Huang, Zhihao Wu, Yu Cao, Minglin Lang, Bingwei Lu, Bing Zhou 
Evidence for an Age-Dependent Decline in Axon Regeneration in the Adult Mammalian Central Nervous System  Cédric G. Geoffroy, Brett J. Hilton, Wolfram.
Volume 3, Issue 2, Pages (August 2014)
Volume 26, Issue 7, Pages e4 (February 2019)
Mitofusin 2 in Mature Adipocytes Controls Adiposity and Body Weight
Islet Coordinately Regulates Motor Axon Guidance and Dendrite Targeting through the Frazzled/DCC Receptor  Celine Santiago, Greg J. Bashaw  Cell Reports 
Volume 2, Issue 3, Pages (March 2014)
Dysregulation of Microglial Function Contributes to Neuronal Impairment in Mcoln1a- Deficient Zebrafish  Wan Jin, Yimei Dai, Funing Li, Lu Zhu, Zhibin.
Molecular Therapy - Nucleic Acids
XBP-1 Remodels Lipid Metabolism to Extend Longevity
Graded Levels of FGF Protein Span the Midbrain and Can Instruct Graded Induction and Repression of Neural Mapping Labels  Yao Chen, Moosa Mohammadi, John.
The Vomeronasal System Can Learn Novel Stimulus Response Pairings
Hermann Broder Schmidt, Rajat Rohatgi  Cell Reports 
ApoE Receptor 2 Controls Neuronal Survival in the Adult Brain
Volume 28, Issue 8, Pages e4 (August 2019)
Volume 15, Issue 5, Pages (May 2007)
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri  Hideaki Matsui, Naoya Kenmochi, Kazuhiko Namikawa  Cell Reports  Volume 26, Issue 7, Pages 1727-1733.e6 (February 2019) DOI: 10.1016/j.celrep.2019.01.015 Copyright © 2019 The Author(s) Terms and Conditions

Cell Reports 2019 26, 1727-1733.e6DOI: (10.1016/j.celrep.2019.01.015) Copyright © 2019 The Author(s) Terms and Conditions

Figure 1 Degeneration of TH+ Neurons in Nothobranchius furzeri (A) In N. furzeri, the number of dopaminergic neurons in the posterior tuberculum (DC2 and DC4) and of noradrenergic neurons in the locus ceruleus significantly decreased at 3 months. These neurons further decreased at 5 months (ANOVA: dopaminergic [DA]: F = 30.7454, p < 0.0001; noradrenergic [NE]: F = 85.6528, p < 0.0001). A degeneration of the dopaminergic or noradrenergic neurons is not observed even at 24 months in zebrafish (Danio rerio) or medaka (Oryzias latipes). n = 12 fish per group. The bar represents SE. (B) (B1) and (B3) are the representative images of the noradrenergic neurons in the locus ceruleus of N. furzeri at 1 and 5 months, respectively. (B2) and (B4) are the magnified images of the red square regions shown in (B1) and (B3), respectively. (B5–B8) (B5) and (B7) are the representative images of the dopaminergic neurons in the posterior tuberculum at 1 and 5 months, respectively. (B6) and (B8) are the magnified images of the red square regions shown in (B5) and (B7), respectively. Each image is a representative optical section of a thick vibratome specimen. (C) Quantification of TH in the brain of N. furzeri at 1, 3, and 5 months (ANOVA: F = 8.7944, p = 0.0011). n = 10 fish per group. The bar represents SE. Quantification of th mRNA in the brain of N. furzeri at 1 and 5 months. n = 4 fish per group. The bar represents SE. (D) Serotonin-positive neurons in the median raphe. n = 12 fish per group. The bar represents SE. See also Figures S1–S3 and Table S1. Cell Reports 2019 26, 1727-1733.e6DOI: (10.1016/j.celrep.2019.01.015) Copyright © 2019 The Author(s) Terms and Conditions

Figure 2 α-Synuclein Pathology in Nothobranchius furzeri (A) Ubiquitin-positive (A1) and α-synuclein-positive (A2) inclusion bodies are observed. (A3–A6) Ubiquitin-positive aggregates were restricted only to the medulla through the spinal cord at 1 month (A3) and progressed throughout the brain at the later stages (A5 and A6). (A4) shows a magnified image of the red square region shown in (A3). (A7–A9) Ubiquitin-positive aggregates are plotted as black points next to the original images. (A10–A13) α-Synuclein-positive aggregates were restricted only to the medulla through the spinal cord at 1 month (A10) and progressed throughout the brain at the later stages (A12 and A13). (A11) is a magnified image of the red square region shown in (A10). (A14–A16) α-Synuclein-positive aggregates are plotted as black points next to the original images. (B) Quantitative analysis of α-synuclein signals in the hindbrain (Hind), midbrain + diencephalon (Mid + Di), and telencephalon (Tel). α-Synuclein signals were less in the rostral site of the brain at 1 month (ANOVA: F = 129.9273, p < 0.0001) and gradually became abundant in the entire brain at 5 months (ANOVA: F = 80.813, p < 0.0001). n = 5 fish per group. The bar represents SE. (C) (C1) Amount of high-molecular-weight α-synuclein in the SDS-insoluble fraction increased in the brain of 5-month-old N. furzeri. The graph shows quantification of the high-molecular α-synuclein in the SDS-insoluble fraction (ANOVA: F = 21.3795, p < 0.0001). n = 8 fish per group. The bar represents SE. (C2) Dot-blot analysis of α-synuclein fibrils in the brain of N. furzeri. A conformation-specific antibody (rabbit monoclonal anti-α-synuclein filament antibody [MJFR-14-6-4-2]; Abcam) was used to detect α-synuclein fibrils in the brain of N. furzeri. The blot on the left shows specificity of the signals. The single signal disappeared in α-synuclein KO N. furzeri. The blot on the right shows increased fibrils in the brain of 5-month-old N. furzeri. The graph shows quantification of the dot blot (ANOVA: F = 20.0384, p < 0.0001). n = 6 fish per group. (D–F) Progression of α-synuclein pathologies. (D) Schematic illustration of the lysate injection assay. See also Lysate injection assay in STAR Methods. (E) 3,3′-Diaminobenzidine tetrahydrochloride (DAB) immunostaining of N. furzeri and human α-synuclein. N. furzeri α-synuclein (E1) and human α-synuclein (E2) in vehicle-injected wild-type (WT) zebrafish. N. furzeri α-synuclein (E3) and human α-synuclein (E4) in vehicle-injected zebrafish expressing human α-synuclein. N. furzeri α-synuclein (E5) and human α-synuclein (E6) in lysate-injected WT zebrafish. N. furzeri α-synuclein (E7) and human α-synuclein (E8) in lysate-injected zebrafish expressing human α-synuclein. (E9) Number of human α-synuclein inclusion bodies per sagittal section (10 μm). n = 4 fish for each group (lysate-injected zebrafish expressing human α-synuclein versus vehicle-injected zebrafish expressing human α-synuclein). The bar represents SE. (F) Fluorescence immunostaining of N. furzeri α-synuclein (green) and human α-synuclein (magenta). N. furzeri α-synuclein (F1) and human α-synuclein (F2) in vehicle-injected zebrafish expressing human α-synuclein (control). (F3) Merged figure of (F1) and (F2). N. furzeri α-synuclein (F4) and human α-synuclein (F5) in lysate-injected zebrafish expressing human α-synuclein. (F6) Merged figure of (F4) and (F5). White arrows indicate inclusion bodies containing human α-synuclein. N. furzeri α-synuclein (F7) and human α-synuclein (F8) in lysate-injected WT zebrafish (control). (F7) Merged figure of (F8) and (F9). See also Figure S4. Cell Reports 2019 26, 1727-1733.e6DOI: (10.1016/j.celrep.2019.01.015) Copyright © 2019 The Author(s) Terms and Conditions

Figure 3 Rescued Pathologies by α-Synuclein Depletion (A) Profile of α-synuclein-deficient (knockout [KO]) N. furzeri. (A1) Sequences of wild-type (WT) and α-synuclein KO fish (c.40_59del, α-synuclein Δ20/Δ20) are shown. The red square or red characters indicate the lesion with a 20-base pair deletion. (A2) Immunohistochemistry and western blotting show complete depletion of α-synuclein protein in α-synuclein KO (3-month-old) fish. (A3) Kaplan-Meier survival curves of α-synuclein WT and KO N. furzeri. Each fish was separated in one tank 30 days after hatching. n = 12 fish per group. Statistical analysis for the survival curves was performed by log-rank test. The life span of α-synuclein KO N. furzeri was comparable to that of the wild-type. (B) The number of dopaminergic neurons in the posterior tuberculum and of noradrenergic neurons in the locus ceruleus at 1 month (n = 6 fish per group) and 5 months (n = 10 fish per group). The bar represents SE. (C) (C1) and (C3) are the representative images of dopaminergic neurons in the posterior tuberculum in 5-month-old WT and KO fish. (C2) and (C4) are the magnified images of the red square regions shown in (C1) and (C3), respectively. (C5) and (C7) are the representative images of the noradrenergic neurons in the locus ceruleus in the 5-month-old WT and KO fish. (C6) and (C8) are the magnified images of the red square regions in (C5) and (C7), respectively. (D) Western blotting of TH protein in the brain of α-synuclein KO fish (at 1 and 5 months). n = 6 (1 month) and 5 (5 months) fish per group. See also Figures S2 and S5. Cell Reports 2019 26, 1727-1733.e6DOI: (10.1016/j.celrep.2019.01.015) Copyright © 2019 The Author(s) Terms and Conditions